This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignee: Alto Neuroscience, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations by Joshua Jordan in Psychiatric Treatment
Introduction
Joshua Jordan is an accomplished inventor based in Los Altos, CA. He has made significant contributions to the field of psychiatric treatment, particularly in addressing depression and related disorders. With a total of 3 patents to his name, his work focuses on innovative methods for treating patients with specific neurological characteristics.
Latest Patents
One of Joshua Jordan's latest patents is titled "Effective treatment of depression in patients having impaired learning and/or memory or certain EEG characteristics with a benzylpiperazine-aminopyridine agent." This invention involves the use of (4-benzylpiperazin-1-yl)-[2-(3-methylbutylamino)pyridin-3-yl]methanone (NSI-189) or its pharmaceutically acceptable salts. It aims to treat psychiatric conditions where depressive symptoms are prominent, including major depressive disorder, bipolar disorder, and post-traumatic stress disorder, particularly in patients exhibiting impaired learning and/or memory.
Another notable patent is "Method of treatment and selection of patients benefiting from agomelatine based on EEG measurements." This invention relates to the use of agomelatine (or a prodrug or salt thereof) for treating major depressive disorder or bipolar disorder. It emphasizes the selection of patients who would benefit most from this treatment based on EEG measurements.
Career Highlights
Joshua Jordan is currently associated with Alto Neuroscience, Inc., where he continues to develop innovative treatments for mental health conditions. His work is characterized by a strong focus on the intersection of neuroscience and psychiatric care.
Collaborations
Joshua has collaborated with notable professionals in his field, including Amit Etkin and Wei Wu. These collaborations have further enhanced the impact of his inventions and research.
Conclusion
Joshua Jordan's contributions to psychiatric treatment through his innovative patents demonstrate his commitment to improving mental health care. His work continues to pave the way for new therapeutic approaches in treating depression and related disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile